5th Workshop of the European CMT Consortium, 69th ENMC International Workshop: Therapeutic approaches in CMT neuropathies and related disorders 23-25 April 1999, Soestduinen, The Netherlands

Neuromuscular Disorders

Volumn 10, Issue 1, 2000, Pages 69-74

  Martini, Rudolf ^a   Berciano, José ^b   Van Broeckhoven, Christine ^c  

^a Bayerische J   (Germany)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c Laboratory of Molecular Genetics   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 32; MYELIN PROTEIN; NEUROTROPHIN 3; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; TRANSCRIPTION FACTOR;

ANIMAL MODEL; CONFERENCE PAPER; FOOT MALFORMATION; GENE THERAPY; GENETIC ANALYSIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HISTOPATHOLOGY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REHABILITATION; SCHWANN CELL;

ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; DEMYELINATING DISEASES; GENE THERAPY; HUMANS; IMMUNE SYSTEM;

EID: 0033986795     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(99)00095-4     Document Type: Conference Paper

References (21)

1. Nelis E., Timmerman V., De Jonghe P., Van Broeckhoven C., Rautenstrauss B. Molecular genetics and biology of inherited peripheral neuropathies: a fast moving field. Neurogenetics. 1999;DOI 10.007/s100489900067.
2. Nelis E., Haites N., Van Broeckhoven C. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat. 13:1999;11-28.
3. Bähr M., Andres F., Timmerman V., Nelis E., Van Broeckhoven C., Dichans J. Central visual, acoustic and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 gene. J Neurol Neurosurg Psychiatry. 66:1999;202-206.
4. Timmerman V., De Jonghe P., Ceuterick C., De Vriendt E., Löfgren A., Nelis E., Warner L.E., Lupski J.R., Martin J-J., Van Broeckhoven C. Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology. 52:1999;1827-1832.
5. Meier C., Parmantier E., Brennan A., Mirsky R., Jessen K.R. Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J Neurosci. 19:1999;3847-3859.
6. D'Urso D., Ehrhardt P., Müller H.W. Peripheral Myelin Protein 22 and Protein Zero: a novel association in peripheral nervous system myelin. J Neurosci. 19:1999;3396-3403.
7. Sereda M., Griffiths I., Pühlhofer A., Stewart H., Rossner M.J., Zimmermann F., Magyar J.P., Schneider A., Hund E., Meinck H-M., Suter U., Nave K-A. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 16:1996;1049-1060.
8. de Waegh S.M., Lee V.M.Y., Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 68:1992;451-463.
9. Sancho S., Magyar J.P., Aguzzi A., Suter U. Distal axonopathy in peripheral nerves of PMP22 mutant mice. Brain. 122:1999;1563-1577.
10. Frei R., Motzing S., Kinkelin I., Schachner M., Koltzenburg M., Martini R. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J Neurosci. 19:1999;6058-6067.
11. Haase G., Kennel P., Pettmann B., Vigne E., Akli S., Revah F., Schmalbruch H., Kahn A. Gene therapy of motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med. 3:1997;429-436.
12. Fernandez A.M., De la Vega A.G., Torres-Aleman I. Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia. Proc Natl Acad Sci USA. 95:1998;1253-1258.
13. Dyck P.J., Swanson C.L., Low P.A., Bartleson J.D., Lambert E.H. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc. 57:1982;239-246.
14. Mitchell G.W., Bosch E.P., Hart M.N. Response to immunosuppressive theraphy in patients with hereditary motor and sensory neuropathy and associated dysimmune neuromuscular disorders. Eur Neurol. 27:1987;188-196.
15. Gregory R., Thomas P.K., King R.H., Hallam P.J., Malcolm S., Hughes R.A.C., Harding A.E. Coexistence of hereditary motor and sensory neuropathy type Ia and IgM paraproteinemic neuropathy. Ann Neurol. 33:1993;649-652.
16. Gold R., Archelos J.J., Hartung H.P. Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol. 9:1999;343-360.
17. Rautenstrauss B., Liehr T., Fuchs C., Bevot A., Bornemann A., Postler E., Meyermann R., Uhlhaas S., Friedl W., Michaelis R. Mosaicism for Charcot-Marie-Tooth disease type 1A: onset in childhood suggests somatic reversion in early developmental stages. Int J Mol Med. 1:1998;333-337.
18. Wagner R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature. 372:1994;333-335.
19. Haseloff J., Gerlach W.L. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature. 334:1988;585-591.
20. Guénard V., Schweitzer B., Flechsig E., Hemmi S., Martini R., Suter U., Schachner M. Effective gene transfer of lacZ and P0 into Schwann cells of P0-deficient mice. Glia. 25:1999;165-178.
21. Huxley C., Passage D., Robertson A.M., Youl B., Huston S., Manson A., Saberan-Djoniedi D., Figarella-Branger D., Pellissier J.F., Thomas P.K., Fontes M. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet. 7:1998;449-458.